Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Mid-range Performer
1474.2000 -35.60 (-2.36%)
NSE Jan 02, 2026 15:31 PM
Volume: 637.7K
 

1474.20
-2.36%
Karvy
Strong Position in North India, Expanding in South and West Regions: Dr. Lal Path Labs is the second largest diagnostic chain in domestic market with healthy balance sheet and strong cash flows. The company gets 72% of revenue from North India, and is concentrating more on an engagement model between thecompany and the clients. The future acquisitions and partnerships would provide operating synergies and basis for organic growth in these new regions.
Dr. Lal Pathlabs Ltd. is trading above its 30 day SMA of 1473.8
More from Dr. Lal Pathlabs Ltd.
Recommended